Buy Aptevo Therapeutics Stock | APVO Stock Price & Latest News | Public.com
APVO

Aptevo Therapeutics

$0.00 (0.00%)Today
    Small Market Cap
    View Aptevo Therapeutics (APVO) stock trends here

    About APVO

    Aptevo Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on developing novel immunotherapies for the treatment of cancer. Its pipeline APVO436, ALG.APV-527 and APVO603 were developed based on the ADAPTIR modular protein platform technology and ...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.72
    -1.43
    -2.15
    Q2 2020
    Q3 2020
    Q4 2020
    Q1 2021

    Expected EPS
    Q1 2021

    -$1.33

    Actual EPS
    Q1 2021

    Stats

    Market Cap$142,22M
    Volume20,93k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$60.00
    1 Year Low$2.94
    Open$32.39
    High$33.63
    Low$30.64

    Buy any stock with any amount of money.

    Download the App
    Download the app